Guoqing Wei
Overview
Explore the profile of Guoqing Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
3460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei G, Xiao T, Xi Y, Ju R
Mater Today Bio
. 2025 Mar;
31:101575.
PMID: 40051528
The innate immune system's inactivation and microbial biofilm-induced antibiotic resistance are the main causes of implant-associated infections (IAIs), which frequently result in implant surgical failure. Refractory recolonization is the consequence...
2.
Yang T, Dong Y, Shi J, Zhang M, Kong D, Feng J, et al.
J Adv Res
. 2025 Feb;
PMID: 39947324
Introduction: CAR-T cell therapy has revolutionized the therapeutic landscape for relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), and bridging with allogeneic hematopoietic stem cell transplantation (allo-HSCT) has the potential to...
3.
Zheng J, Zhou Y, Zhao Y, Luo Y, Yu J, Lai X, et al.
Ann Hematol
. 2025 Jan;
PMID: 39843812
The aim of this study was to develop and validate a nomogram predicting progression-free survival (PFS) for adult patients with positive acute lymphoblastic leukemia(Ph + ALL) who have undergone allogeneic...
4.
Liu G, Zeng Y, Wang D, Wang S, Zan Y, Wei G
Sci Rep
. 2025 Jan;
15(1):1681.
PMID: 39799167
When underground tunnels in coal mines traverse geological structurally abnormal zones (faults, collapse columns, fractured zones, etc.), excavation-induced unloading leads to instability and failure of the engineering rock mass. Rock...
5.
Yang T, Dong Y, Zhang M, Feng J, Fu S, Xiao P, et al.
Exp Hematol Oncol
. 2025 Jan;
14(1):2.
PMID: 39754190
Background: Sequential CD19 and CD22 chimeric antigen receptor (CAR)-T cell therapy offers a promising approach to antigen-loss relapse in relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL); however, research in adults...
6.
Jiang B, Yang T, Zhao Y, Luo Y, Ouyang G, Yu J, et al.
Bone Marrow Transplant
. 2024 Dec;
60(3):326-334.
PMID: 39627346
Patients with TP53-mutated myelodysplastic neoplasms (MDS) have unfavorable prognoses; the benefit of cytoreductive treatment before hematopoietic stem cell transplantation (HSCT) is debated. We retrospectively analyzed 284 MDS patients undergoing allogeneic...
7.
Chen R, Jin C, Liu K, Zhao M, Yang T, Zhang M, et al.
Chin Med J (Engl)
. 2024 Nov;
PMID: 39501801
Background: B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T (CAR-T) therapy yield remarkable responses in patients with relapsed/refractory multiple myeloma (R/RMM). Circulating tumor DNA (ctDNA) reportedly exhibits distinct advantages in...
8.
Zheng J, Zhao Y, Luo Y, Yu J, Lai X, Wang J, et al.
Ann Hematol
. 2024 Jul;
103(8):2983-2991.
PMID: 38963448
Additional chromosomal abnormalities(ACAs) at diagnosis are associated with inferior prognosis in chronic myeloid leukemia. However, the prognostic significance of ACAs in adult patients with Philadelphia Chromosome Positive acute lymphoblastic leukemia...
9.
Zhang Q, Jiang Y, Zhang X, Wang Y, Ju R, Wei G
Biomater Res
. 2024 Jun;
28:0019.
PMID: 38938648
The management of infected wounds poses a significant challenge due to the growing issue of antibiotic resistance, underscoring the urgent necessity to innovate and implement alternative therapeutic strategies. These strategies...
10.
Hu Y, Zhang M, Yang T, Mo Z, Wei G, Jing R, et al.
N Engl J Med
. 2024 Apr;
390(16):1467-1480.
PMID: 38657244
Background: Patients with relapsed or refractory hematologic cancers have a poor prognosis. Chimeric antigen receptor (CAR) T-cell therapy as a bridge to allogeneic hematopoietic stem-cell transplantation (HSCT) has the potential...